Replimune (REPL) Interest Coverage Ratio (2019 - 2026)
Replimune (REPL) posted Interest Coverage Ratio of 20.25 for Q1 2026, down 1072.72% sequentially from 1.73 in Q4 2025, and down 102.96% YoY from 683.86 in Q1 2025.
Powered by 
Analysis
Replimune (REPL) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Replimune has reported Interest Coverage Ratio for 10 years, with the latest figure at 20.25 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 102.96% year-over-year to 20.25 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 40.35 (up 37.3% YoY) and the FY2026 annual result came in at 1.03, up 13.15% from the prior year.
- Interest Coverage Ratio eased to 20.25 in Q1 2026 per REPL's latest filing, from 1.73 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 683.86 in Q1 2025 and troughed at 27.0 in Q1 2023.
- A 5-year average of 42.88 and a median of 1.31 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio tumbled 120.42% in 2023, then surged 2964.36% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 0.84 in 2022, then plunged by 43.37% to 1.2 in 2023, then dropped by 23.86% to 1.49 in 2024, then decreased by 16.13% to 1.73 in 2025, then sank by 1072.72% to 20.25 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 20.25, 1.73, and 1.99 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 1.42 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.08 |
| 10 | Replimune | 1.45 Bn | 1.45 Bn | - | -26.44 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.44 |
| Mar 31, 2026 | -30.98 |
| Dec 31, 2025 | -49.02 |
| Sep 30, 2025 | -56.65 |
| Jun 30, 2025 | -61.30 |
| Mar 31, 2025 | -54.30 |
| Dec 31, 2024 | -45.53 |
| Sep 30, 2024 | -40.97 |
| Jun 30, 2024 | -40.23 |
| Mar 31, 2024 | -41.55 |
| Dec 31, 2023 | -55.87 |
| Sep 30, 2023 | -66.84 |
| Jun 30, 2023 | -49.91 |
| Mar 31, 2023 | -51.85 |
| Dec 31, 2022 | -44.24 |
| Mar 31, 2021 | -22,184.00 |
| Dec 31, 2020 | -82.09 |
| Sep 30, 2020 | -68.75 |
| Jun 30, 2020 | -62.79 |
| Mar 31, 2020 | 55.54 |